SCHEMBL3280893

SCHEMBL3280893

COS(=O)(=O)c1cccc(C)c1

nearest known ligand 0.59

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.52
MEN1 O00255 1/20 0.45
ACHE P22303 2/20 0.44
F2 P00734 1/20 0.43
HTR6 P50406 1/20 0.43
ALDH1A1 P00352 2/20 0.42
HTT P42858 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
FBP1 P09467 8/20 0.42
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41
MMP2 P08253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27558016 0.98 KMT2A (0.50) KMT2AMEN1ACHEF2HTR6
SCHEMBL779123 0.87 CA1 (0.48) KMT2AMEN1F2HTR6ALDH1A1
SCHEMBL31435685 0.85 KMT2A (0.53) KMT2AMEN1ACHEF2HTR6
SCHEMBL6113188 0.85 KMT2A (0.53) KMT2AMEN1ACHEF2HTR6
SCHEMBL12757787 0.82 KMT2A (0.50) KMT2AMEN1ACHEF2HTR6
SCHEMBL9405003 0.82 KMT2A (0.50) KMT2AMEN1ACHEF2HTR6
SCHEMBL27472685 0.82 KMT2A (0.50) KMT2AMEN1ACHEF2HTR6
SCHEMBL21776939 0.80 KMT2A (0.49) KMT2AMEN1ACHEF2HTR6
SCHEMBL8397924 0.79 KMT2A (0.47) KMT2AMEN1ACHEF2HTR6
SCHEMBL3279948 0.79 KMT2A (0.51) KMT2AMEN1F2HTR6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9562425-B2 Methods of enhancing the conductivity of propped fractures with in-situ acidizing HALLIBURTON ENERGY SERVICES, INC. (US) 2017-02-07 US claimed
WO-2014099667-A1 METHODS OF ENHANCING THE CONDUCTIVITY OF PROPPED FRACTURES WITH IN-SITU ACIDIZING HALLIBURTON ENERGY SERVICES, INC. (US) 2014-06-26 WO claimed
US-20140166286-A1 Methods of Enhancing the Conductivity of Propped Fractures with In-Situ Acidizing HALLIBURTON ENERGY SERVICES, INC. (US) 2014-06-19 US claimed
US-7704927-B2 Method of acid fracturing a sandstone formation BJ SERVICES COMPANY (US) 2010-04-27 US claimed
US-20090281005-A1 METHOD OF ACID FRACTURING A SANDSTONE FORMATION BJ SERVICES COMPANY 2009-11-12 US claimed
US-20250389171-A1 DUAL-ACTING DELAYED FILTERCAKE BREAKER FLUID HALLIBURTON ENERGY SERVICES, INC. (US) 2025-12-25 US disclosed
US-12503930-B1 Dual-acting delayed filtercake breaker fluid HALLIBURTON ENERGY SERVICES, INC. (US) 2025-12-23 US disclosed
US-11661815-B1 Resins for repair of well integrity issues HALLIBURTON ENERGY SERVICES, INC. (US) 2023-05-30 US disclosed
US-10011764-B2 Porous cement composition for propping fractures open HALLIBURTON ENERGY SERVICES, INC. (US) 2018-07-03 US disclosed
US-9938810-B2 Conductivity enhancement of complex fracture networks in subterranean formations HALLIBURTON ENERGY SERVICES, INC. (US) 2018-04-10 US disclosed
US-9562425-B2 Methods of enhancing the conductivity of propped fractures with in-situ acidizing HALLIBURTON ENERGY SERVICES, INC. (US) 2017-02-07 US disclosed
US-20160237341-A1 POROUS CEMENT COMPOSITION FOR PROPPING FRACTURES OPEN HALLIBURTON ENERGY SERVICES, INC. 2016-08-18 US disclosed
US-20120122773-A1 N-SUBSTITUTED-CYCLIC AMINO DERIVATIVE DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-05-17 US disclosed
US-7704927-B2 Method of acid fracturing a sandstone formation BJ SERVICES COMPANY (US) 2010-04-27 US disclosed
US-20090281005-A1 METHOD OF ACID FRACTURING A SANDSTONE FORMATION BJ SERVICES COMPANY 2009-11-12 US disclosed
US-20090226808-A1 Nonaqueous Electrolyte Solution and Lithium Secondary Battery Using Same MITSUI CHEMICALS, INC. (JP) 2009-09-10 US disclosed
EP-0773235-B1 Polymerization of alpha-olefins MITSUBISHI CHEM CORP (JP) 1999-05-26 EP disclosed
EP-0759445-B1 Catalyst for olefin polymerization and method for producing olefin polymers using the same MITSUBISHI CHEM CORP (JP) 1999-03-17 EP disclosed
EP-0773235-A1 Polymerization of alpha-olefins MITSUBISHI CHEMICAL CORPORATION (JP) 1997-05-14 EP disclosed
EP-0759445-A1 Catalyst for olefin polymerization and method for producing olefin polymers using the same MITSUBISHI CHEMICAL CORPORATION (JP) 1997-02-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250389171-A1 DUAL-ACTING DELAYED FILTERCAKE BREAKER FLUID DKK1, NSF, TRPC7 KMT2A 3787/4885MEN1 2629/4885ACHE 1231/4885
US-20120122773-A1 N-SUBSTITUTED-CYCLIC AMINO DERIVATIVE REN, AGTR1, AGTR2 KMT2A 1646/4885MEN1 1004/4885ACHE 2217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.